HerbSprout.com

Mobilezinger

, , , , , ,
, , , , , , , , ,
No comments on AP2A1 New anti-aging pathway; how effective is it?

AP2A1 New anti-aging pathway; how effective is it?

When Osaka University scientists discovered the new AP2A1 cells and their role in aging, they weren’t expecting a second role it plays in aging. AP2A1 reversed several markers of aging in the dish, according to a June 8 2026 report by the NutriGenomics Institute. It adds that Cellular Signalling suggests AP2A1 may become a new therapeutic target for age-related diseases. It may also improve cellular health during aging.

An updated July 2026 Panacea Cell & Biology report says researchers at Osaka University found a second, unexpected function AP2A1 plays in the aging of cells. They found that higher AP2A1 ages younger cells, while lowering AP2A1 may reverse several markers of aging.

Osaka University’s Pirawan Chantachotikul, Shinji Deguchi and colleagues studied why old cells look so different from young ones; when cells enter replicative senescence, it stops dividing and balloons in size, as opposed to smaller, younger cells.

Researchers believe this understanding points toward the possibility of manipulating and reducing AP2A1’s role in aging.

1) https://nutrigenomicsinstitute.com/nutrigenomics-news/ap2a1-the-protein-that-could-open-a-new-pathway-to-rejuvenate-aged-cells/

2) https://ap2a1.com

Mobilezinger's avatar

Posted by:

Mobilezinger

Herbsprout is a blog and podcast about the health benefits of our gut microbiome, natural remedies, and healthcare innovations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . The contents of this webblog is not intended to be used to treat, cure, mitigate, or diagnose any medical condition. The readers must consult your doctor before you make any changes that could affect your health. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ADVISORY BOARD: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ●Jenny Pandol, Co-owner/founder/ COO, Microbiome Learning Center; 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ●Dr. Sabine Hazan, Founder and CEO, Progenabiome and Ventura Clinical Trials;
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ●Naveen Jain, Founder & CEO, Viome 
. . . . . . . . . . . . . . . . . . . . . . . ●Hans Parge, ex-Pfizer director; . . . . . . . . . . . . . . . . . . . . . . . . . . . . ●Chris Kenji Beer, health research/writer . . . . . . . . . . . . . . . . . . ●Ely Diana, translation/support

Leave a comment